Company Filing History:
Years Active: 2022-2025
Title: Christina Rostad: Innovator in Immunogenic Compositions
Introduction
Christina Rostad is a prominent inventor based in Atlanta, GA (US). She has made significant contributions to the field of immunology, particularly in the development of vaccines. With a total of 2 patents, her work focuses on innovative solutions to combat respiratory syncytial virus (RSV).
Latest Patents
Rostad's latest patents include groundbreaking research on chimeric respiratory syncytial virus (RSV) and immunogenic compositions. These patents detail a live attenuated vaccine and methods of use that involve a chimeric RSV with a specific mutated gene pattern. The RSV F protein encoded in this virus has critical mutations at positions 79 (M), 191 (R), 357 (K), and 371 (Y), which are essential for its immunogenic properties.
Career Highlights
Christina Rostad is affiliated with Emory University, where she conducts her research and development work. Her dedication to advancing vaccine technology has positioned her as a key figure in the fight against viral infections.
Collaborations
Rostad collaborates with various professionals in her field, including her coworker Martin L Moore. Their combined expertise enhances the research efforts at Emory University, leading to innovative breakthroughs in immunology.
Conclusion
Christina Rostad's contributions to the field of immunology through her patents and research at Emory University highlight her role as a leading inventor. Her work on chimeric RSV and immunogenic compositions is paving the way for future advancements in vaccine development.